Skip to main content
. 2020 Aug 6;15:5855–5871. doi: 10.2147/IJN.S247088

Figure 5.

Figure 5

VCM release and OB cells biocompatibility evaluation in vitro. (A) In vitro release profiles of VCM-NPs, VCM/Gel and VCM-NPs/Gel. (B and C) CCK-8 results of OB cells treated with VCM-NPs, VCM/Gel and VCM-NPs/Gel with different concentration at 24 h and 72 h, respectively. (D) ALP activity of OB cells treated with VCM-NPs, VCM/Gel and VCM-NPs/Gel with different concentration at 7 days. *P< 0.05; ***P< 0.001.